• 1. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinoline carboxylic acids

Introduction to 4-hydroxy-7-methylquinoline-3-carboxylic Acid (CAS No. 256923-25-8)

4-hydroxy-7-methylquinoline-3-carboxylic Acid, identified by the Chemical Abstracts Service registry number CAS No. 256923-25-8, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic research. This compound belongs to the quinoline family, a class of molecules known for their diverse biological activities and applications in medicinal chemistry. The structural features of 4-hydroxy-7-methylquinoline-3-carboxylic Acid, particularly the presence of both hydroxyl and methyl substituents on the quinoline ring, contribute to its unique chemical properties and potential therapeutic utilities.

The quinoline scaffold has a long history in medicinal chemistry, with numerous derivatives exhibiting antimicrobial, antimalarial, and anticancer properties. Among these derivatives, 4-hydroxy-7-methylquinoline-3-carboxylic Acid stands out due to its specific substitution pattern, which may influence its interactions with biological targets. The hydroxyl group at the 4-position and the methyl group at the 7-position are key functional moieties that can modulate the compound's reactivity and biological activity.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to explore the binding modes of 4-hydroxy-7-methylquinoline-3-carboxylic Acid with various biological targets. Studies suggest that this compound may interact with enzymes and receptors involved in inflammation and cancer progression. The hydroxyl group at the 4-position could serve as a hydrogen bond acceptor, while the methyl group at the 7-position might enhance hydrophobic interactions with protein binding pockets. These interactions could potentially lead to the development of novel therapeutic agents targeting these pathways.

In vitro studies have begun to elucidate the pharmacological profile of 4-hydroxy-7-methylquinoline-3-carboxylic Acid. Preliminary results indicate that this compound exhibits moderate activity against certain cancer cell lines, possibly through inhibition of key signaling pathways. Additionally, its ability to modulate inflammatory responses has been observed in preliminary assays, suggesting potential applications in treating chronic inflammatory diseases. These findings align with broader trends in drug discovery, where quinoline derivatives are being revisited for their therapeutic potential.

The synthesis of 4-hydroxy-7-methylquinoline-3-carboxylic Acid presents both challenges and opportunities for synthetic chemists. Traditional synthetic routes often involve multi-step processes that require careful optimization to achieve high yields and purity. However, recent methodologies have leveraged transition metal catalysis and asymmetric synthesis to streamline these processes. For instance, palladium-catalyzed cross-coupling reactions have been employed to construct the quinoline core efficiently. Such advances not only enhance scalability but also reduce the environmental impact of synthesis.

The pharmacokinetic properties of 4-hydroxy-7-methylquinoline-3-carboxylic Acid are also under investigation. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is crucial for its development into a viable drug candidate. Preliminary pharmacokinetic studies suggest that 4-hydroxy-7-methylquinoline-3-carboxylic Acid exhibits moderate solubility in water and lipids, which could influence its bioavailability. Further research is needed to optimize these properties through structural modifications.

One of the most exciting aspects of 4-hydroxy-7-methylquinoline-3-carboxylic Acid is its potential as a scaffold for drug discovery. By leveraging structure-based drug design principles, chemists can modify this molecule to enhance its potency, selectivity, and pharmacokinetic profile. For example, introducing additional functional groups or exploring different substitution patterns could lead to derivatives with improved therapeutic efficacy. Collaborative efforts between computational chemists, medicinal chemists, and biologists are essential to realize this potential fully.

The role of 4-hydroxy-7-methylquinoline-3-carboxylic Acid in addressing unmet medical needs cannot be overstated. With an aging global population and rising rates of chronic diseases, there is a growing demand for innovative therapeutic agents. Quinoline derivatives like 4-hydroxy-7-methylquinoline-3-carboxylic Acid offer a rich structural framework for developing new treatments targeting various diseases. As research progresses, it is likely that this compound will play an increasingly important role in clinical applications.

In conclusion,4-hydroxy-7-methylquinoline-3-carboxylic Acid (CAS No. 256923-25-8) is a promising compound with significant potential in pharmaceutical research. Its unique structural features, combined with recent advances in synthetic methodologies and computational biology, position it as a valuable scaffold for drug discovery. Further exploration of its biological activities and pharmacokinetic properties will be crucial in realizing its full therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)